Home / Mutual Funds / News /  HDFC MF's Prashant Jain & team raise stakes in these pharma stocks in March
Listen to this article

Equity mutual funds attracted an all-time high net inflow of 28,463 crore in March on continued interest by investors. This was significantly higher than the net inflow of 19,705 crore in February, 14,888 crore in January and 25,077 crore in December 2021, data from the Association of Mutual Funds in India (AMFI) showed. 

HDFC Mutual Fund's large additions were HDFC ( 17.16 bn), HDFC Bank ( 11.8 bn) and UltraTech Cement ( 3.18 bn). It's prominent reductions were ITC, NHPC Ltd and Adani Wilma. Zydus Wellness and Sudarshan Chem were new entrants while L&T Fin Holdings was a complete exit, the fund house's data accumulated by Edelweiss showed.

The team of fund managers at HDFC AMC, headed by Prashant Jain have increased shareholding in pharma stocks like Alembic Pharma (increased holding by 2,31,543 shares), Ipca Labs (raised holding by 30,000 shares), and Torrent Pharma (increased by 36,313 shares), as per the Fund Manager wise holdings data analyzed for the month of March 2022 by Edelweiss.

Overall, the mutual fund (MF) industry registered a net outflow of 69,883 crore in March, as compared to a net infusion of 31,533 crore in the preceding month. The outflow pulled down the average assets under management (AUM) of the industry to 37.7 lakh crore at the end of March, from 38.56 lakh crore at February-end.

Further, monthly Systematic Investment Plan (SIP) contribution collected reached an all-time high at 12,328 crore, up almost 8% from 11,438 crore in February 2022.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.
Recommended For You
Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsFeedbackRedeem a Gift CardLogout